CD8A and neoplasm: Subsequent spatial differential abundance analysis illustrated a gradual decrease in CD8+ effector T cells correlating with tumor progression, alongside an increase in tissue-resident CD8+ T cells primarily localized in tumor and adjacent areas (Figures 4D–F; Supplementary Figure S2F–H).